Apollo, Asia’s foremost integrated healthcare services provider announced the launch of an Antimicrobial Stewardship Program (Apollo ASP) at a national level. The program will sensitize care providers on Antimicrobial resistance AMR, an issue leading to a public health problem and is today one of humanity’s top ten global public health threats.
Dr. Prathap C. Reddy, Chairman, Apollo said, “Antimicrobial Stewardship Program (Apollo ASP) will be the largest program of its kind in the country to promote the rational use of antibiotics to combat the rising burden of antimicrobial resistance (AMR), also known as drug resistance in the community. The program will sensitize care providers on AMR, an issue leading to a public health problem and is today one of humanity’s top ten global public health threats. Through the Apollo Antimicrobial Stewardship Program, we aim to optimize the use of antibiotics, turn the tide on AMR, and ensure continued effective treatment of infections for future generations.”
According to Dr. Sangita Reddy, Joint Managing Director, Apollo, “The Apollo Antimicrobial Stewardship Program or Apollo ASP is being launched across the group to improve antimicrobial use and patient outcomes. Apollo ASP will also support the Government of India’s National action plan on the containment of Antimicrobial Resistance (NAP-AMR) and ICMR’s AMR surveillance and research network (AMRSN) to control AMR by empowering doctors to use antibiotics judiciously. Our recent data of over 300 thousand bacterial isolates since 2019 across 20 different locations in India shows a considerable increase in community-acquired Antimicrobial Resistance which warrants immediate measures to stop this emerging trend. Integrating these insights into clinical decision-making would foster a culture of rational antibiotic use and save lives.”